Shu Hui Chen
Corporate Officer/Principal en WUXI PHARMATECH (CAYMAN) INC. (ADR) .
Perfil
En la actualidad, Shu Hui Chen es vicepresidente de WuXi AppTec Co., Ltd. y director científico de Wuxi PharmaTech (Cayman) Inc. En el pasado fue asesor de investigación en Eli Lilly & Co., director asociado de química en Vion Pharmaceuticals, Inc. e investigador principal en Bristol-Myers Squibb Co. El Dr. Chen se doctoró en la Universidad de Yale y se licenció en la Universidad de Fudan.
Cargos activos de Shu Hui Chen
Empresas | Cargo | Inicio |
---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - |
WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 01/01/2004 |
Antiguos cargos conocidos de Shu Hui Chen.
Empresas | Cargo | Fin |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2004 |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/01/1997 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1995 |
Formación de Shu Hui Chen.
Yale University | Doctorate Degree |
Fudan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |